Akili

IPO

Akili Interactive

Public · Boston, United States · Founded 2011 · $178.0M raised

Employees
51–200
Founded
2011
Business Model
B2C
Total Funding
$178.0M
Last Round
$110.0M Series DApr 2021
Rounds
7
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Akili Interactive is a digital therapeutics company creating a new class of cognitive medicines delivered through engaging video game experiences. Its flagship products, EndeavorRx (FDA-authorized for children with ADHD) and EndeavorOTC (clinically proven for adults with ADHD), combine neuroscience with proprietary game-based technology to improve attention and focus.

Summary

Akili is a Biotech company based in Boston, United States, founded in 2011. It has raised $178.0M in total across 7 rounds, most recently a $110.0M Series D round in Apr 2021. Investors include Polaris Partners, Temasek and Social Capital.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

AcquisitionMay 2024

Sign up to see all 10 events

Funding: Angel through Series D. Amounts, valuations, and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Akili on Indexed.vc
<a href="https://indexed.vc/companies/akili"><img src="https://indexed.vc/api/badge/company/akili" alt="Akili on Indexed.vc" width="260" height="76" /></a>